These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7103786

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.
    Waters CH, Nausieda P, Dzyak L, Spiegel J, Rudzinska M, Silver DE, Tsurkalenko ES, Kell S, Hsu A, Khanna S, Gupta S.
    CNS Drugs; 2015 Apr; 29(4):341-50. PubMed ID: 25895021
    [Abstract] [Full Text] [Related]

  • 24. [Levodopa: the story continues].
    Titova NV, Katunina EA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014 Apr; 114(9):93-9. PubMed ID: 25473661
    [Abstract] [Full Text] [Related]

  • 25. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease.
    Melamed E.
    Arch Neurol; 1979 May; 36(5):308-10. PubMed ID: 444100
    [Abstract] [Full Text] [Related]

  • 26. Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
    Pouclet H, Derkinderen P, Lebouvier T.
    Clin Neurol Neurosurg; 2013 Feb; 115(2):235-6. PubMed ID: 22743235
    [No Abstract] [Full Text] [Related]

  • 27. Dystonic foot response of Parkinsonism.
    Nausieda PA, Weiner WJ, Klawans HL.
    Arch Neurol; 1980 Mar; 37(3):132-6. PubMed ID: 7356417
    [Abstract] [Full Text] [Related]

  • 28. Parkinson's disease, depression, and the on-off phenomenon.
    Friedenberg DL, Cummings JL.
    Psychosomatics; 1989 Mar; 30(1):94-9. PubMed ID: 2913602
    [No Abstract] [Full Text] [Related]

  • 29. Meige's syndrome: clinical, pharmacological and radiological observations.
    Chopra JS, Radhakrishnan K, Sridharan R.
    Clin Neurol Neurosurg; 1981 Mar; 83(3):145-52. PubMed ID: 6274556
    [Abstract] [Full Text] [Related]

  • 30. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE, Tolosa ES, Loewenson RB, Lee MC, Resch JA, Baker AB.
    Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
    [No Abstract] [Full Text] [Related]

  • 31. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features.
    Catalán MJ, Escribano PM, Alonso-Frech F.
    Mov Disord; 2017 Apr; 32(4):624-625. PubMed ID: 28116835
    [No Abstract] [Full Text] [Related]

  • 32. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
    Antonini A, Fung VS, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA.
    Mov Disord; 2016 Apr; 31(4):530-7. PubMed ID: 26817533
    [Abstract] [Full Text] [Related]

  • 33. False positive diagnosis of phaeochromocytoma in a patient with Parkinson's disease receiving levodopa.
    Quinn N, Carruthers M.
    J Neurol Neurosurg Psychiatry; 1988 May; 51(5):728-9. PubMed ID: 3404174
    [No Abstract] [Full Text] [Related]

  • 34. Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion.
    Martino T, Melchionda D, Tonti P, De Francesco V, Lalla A, Specchio LM, Avolio C.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1395-1398. PubMed ID: 27614656
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R.
    Neurol Neurocir Psiquiatr; 1976 Dec; 17(4):293-300. PubMed ID: 1018729
    [Abstract] [Full Text] [Related]

  • 36. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.
    Gilligan B, Wodak J, Stark R, O'Halloran M.
    Med J Aust; 1979 Aug 25; 2(4):205-7. PubMed ID: 390336
    [Abstract] [Full Text] [Related]

  • 37. Forms of dystonia in patients with Parkinson's disease.
    Kidron D, Melamed E.
    Neurology; 1987 Jun 25; 37(6):1009-11. PubMed ID: 3587617
    [Abstract] [Full Text] [Related]

  • 38. Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease.
    Meloni M, Solla P, Mascia MM, Marrosu F, Cannas A.
    Parkinsonism Relat Disord; 2017 Apr 25; 37():92-96. PubMed ID: 28063683
    [Abstract] [Full Text] [Related]

  • 39. Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa.
    Burdick DJ, Griffith A, Agarwal P.
    Mov Disord; 2013 Mar 25; 28(3):295. PubMed ID: 23526432
    [No Abstract] [Full Text] [Related]

  • 40. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW.
    Mov Disord; 2000 May 25; 15(3):485-9. PubMed ID: 10830413
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.